US2021187017A1PendingUtilityA1
Composition and method for the prevention and treatment of obesity
Est. expiryDec 20, 2039(~13.4 yrs left)· nominal 20-yr term from priority
A61K 31/197A61K 9/0019A61K 9/0053A61K 33/30
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for reducing the weight of an overweight or obese subject comprising administering a therapeutically effective amount of a composition comprising 64Zn-enriched zinc. A method for preventing or reducing weight gain comprising administering an effective amount of a composition comprising 64Zn-enriched zinc.
Claims
exact text as granted — not AI-modified1 . A method of preventing overweightness or obesity comprising administering to a subject in need thereof a prophylactically or therapeutically effective amount composition comprising a 64 Zn e compound or a salt thereof, wherein the 64 Zn e compound or a salt thereof is at least 80% 64 Zn e .
2 . The method of claim 1 , wherein the composition further comprises a diluent or an excipient.
3 . The method of claim 2 , wherein the diluent is deuterium-depleted water.
4 . The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 95% 64 Zn e .
5 . The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 99% 64 Zn e .
6 . The method of claim 1 , wherein the composition contains between 0.05 mg and 110 mg of 64 Zn e .
7 . The method of claim 6 , wherein the composition contains between 1 and 10 mg of 64 Zn e .
8 . The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 90% 64 Zn e and the composition is an aqueous solution in which 64 Zn e is present at a concentration of between 0.1 mg/ml and 10 mg/ml.
9 . The method of claim 1 , wherein 64 Zn e is in a form of salt selected from the group consisting of zinc aspartate with 2 aspartic acid molecules, zinc sulfate, and zinc citrate wherein the zinc aspartate has the structure
10 . The method of claim 1 , wherein the composition is administered by injection.
11 . The method of claim 1 , wherein the composition is administered orally.
12 . A method of treating overweightness or obesity comprising administering to a subject in need thereof a prophylactically or therapeutically effective amount composition comprising a 64 Zn e compound or a salt thereof, wherein the 64 Zn e compound or a salt thereof is at least 80% 64 Zn e , wherein 64 Zn e is in a form of salt selected from the group consisting of zinc aspartate with 2 aspartic acid molecules, zinc sulfate, and zinc citrate, wherein the zinc aspartate has the structureCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.